Volume 20 Issue 11
Nov.  2022
Turn off MathJax
Article Contents
ZHAO Xu-ran, GAO Jin-e, NA Ri-song, HAI Rong, ZHANG Peng-fei. Clinical study on the correlation between sarcopenic obesity and hypertension in elderly subjects[J]. Chinese Journal of General Practice, 2022, 20(11): 1874-1877. doi: 10.16766/j.cnki.issn.1674-4152.002724
Citation: ZHAO Xu-ran, GAO Jin-e, NA Ri-song, HAI Rong, ZHANG Peng-fei. Clinical study on the correlation between sarcopenic obesity and hypertension in elderly subjects[J]. Chinese Journal of General Practice, 2022, 20(11): 1874-1877. doi: 10.16766/j.cnki.issn.1674-4152.002724

Clinical study on the correlation between sarcopenic obesity and hypertension in elderly subjects

doi: 10.16766/j.cnki.issn.1674-4152.002724
Funds:

 2018YFC2002100

 2022YN20

  • Received Date: 2021-12-28
    Available Online: 2022-12-30
  •   Objective  To explore the correlation between sarcopenic obesity and hypertension in the elderly, and to provide reference for clinical prevention and treatment of hypertension in the elderly.  Methods  Two hundred and ten elderly patients hospitalized in Geriatric Medicine Center of Inner Mongolia People's Hospital from January 2018 to January 2021 were selected. Among them, 134 (63.81%) were hypertensive and 76 (36.19%) were non-hypertensive. Height, body mass, appendicular skeletal muscle mass (ASM), grip strength, blood glucose, blood lipid, liver function and kidney function were measured. Body mass index (BMI) and relative skeletal muscle index (RSMI) were calculated and compared.  Results  ASM and RSMI in the hypertension group were lower than those in the non-hypertension group [(14.90±3.38) kg vs. (19.41±1.56) kg, P < 0.001; (5.59±1.37) kg/m2 vs. (7.11 ±0.84) kg/m2, P < 0.001]. The age and BMI of the hypertension group were higher than those of the non-hypertension group [(72.79±7.20) years vs. (70.79±6.51) years, P=0.046; 25.66±3.48 vs. 24.46±2.81, P=0.011]. The prevalence rate of sarcopenia and sarcopenic obesity in the hypertensive group was higher than those in the non-hypertensive group (67.91% vs. 38.16%, P < 0.001; 25.37% vs. 2.63%, P < 0.001). Multivariate logistic regression analysis showed that age, sarcopenia and sarcopenic obesity were the risk factors of hypertension in the elderly.  Conclusion  ASM is closely related to hypertension, and high ASM is a protective factor of hypertension in the elderly. Sarcopenic obesity and sarcopenia are important risk factors of hypertension in the elderly.

     

  • loading
  • [1]
    李静, 范利, 华琦, 等. 中国老年高血压管理指南2019[J]. 中华高血压杂志, 2019, 27(2): 111-135. doi: 10.16439/j.cnki.1673-7245.2019.02.008

    LI J, FAN L, HUA Q, et al. 2019 Chinese guidelines for the management of hypertension in the elderly[J]. Chinese Journal of Cardiovascular Medicine, 2019, 27(2): 111-135. doi: 10.16439/j.cnki.1673-7245.2019.02.008
    [2]
    吉彤, 汤哲, 李耘, 等. 老年人少肌性肥胖的诊断标准现况[J]. 实用老年医学, 2021, 35(1): 74-76. doi: 10.3969/j.issn.1003-9198.2021.01.020

    JI T, TANG Z, LI Y, et al. Status of diagnostic criteria for sarcopenic obesity in the elderly[J]. Practical Geriatrics, 2021, 35(1): 74-76. doi: 10.3969/j.issn.1003-9198.2021.01.020
    [3]
    KREIDIEH D, ITANI L, El MASRI D, et al. Association between sarcopenic obesity, type 2 diabetes, and hypertension in overweight and obese treatment-seeking adult women[J]. J Cardiovasc Dev Dis, 2018, 5(4): 51-58. doi: 10.3390/jcdd5040051
    [4]
    CHEN L K, WOO J, ASSANTACHAI P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307. doi: 10.1016/j.jamda.2019.12.012
    [5]
    刘莹, 谭寅凤, 张金月, 等. 超重肥胖和正常体重人群肠道菌群的差异分析[J]. 中国临床研究, 2022, 35(1): 21-24. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK202201005.htm

    LIU Y, TAN Y F, ZHANG J Y, et al. Difference of gut microbiota in people with overweight/obese and normal weight[J]. Chinese Journal of Clinical Research, 2022, 35(1): 21-24. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK202201005.htm
    [6]
    DONINI L M, BUSETTO L, BAUER J M, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review[J]. Clin Nutr, 2020, 39(8): 2368-2388. doi: 10.1016/j.clnu.2019.11.024
    [7]
    PONTI F, SANTORO A, MERCATELLI D, et al. Aging and imaging assessment of body composition: From fat to facts[J]. Front Endocrinol(Lausanne), 2020, 10(1): 861-878.
    [8]
    ZHANG X, XIE X, DOU Q, et al. Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: A updated meta-analysis[J]. BMC Geriatr, 2019, 19(1): 183-197. doi: 10.1186/s12877-019-1195-y
    [9]
    HONG S H, CHOI K M. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences[J]. Int J Mol Sci, 2020, 21(2): 494-511. doi: 10.3390/ijms21020494
    [10]
    POLYZOS S A, MARGIORIS A N. Sarcopenic obesity[J]. Hormones (Athens), 2018, 17(3): 321-331. doi: 10.1007/s42000-018-0049-x
    [11]
    ATKINS J L, WANNAMATHEE S G. Sarcopenic obesity in ageing: Cardiovascular outcomes and mortality[J]. Br J Nutr, 2020, 124(10): 1102-1113. doi: 10.1017/S0007114520002172
    [12]
    BAI T, FANG F, LI F, et al. Sarcopenia is associated with hypertension in older adults: A systematic review and meta-analysis[J]. BMC Geriatr, 2020, 20(1): 279-288. doi: 10.1186/s12877-020-01672-y
    [13]
    SASAKI K I, FUKUMOTO Y. Sarcopenia as a comorbidity of cardiovascular disease[J]. J Cardiol, 2022, 79(5): 596-604. doi: 10.1016/j.jjcc.2021.10.013
    [14]
    马璐瑶, 林萍, 王琴, 等. 老年慢性心力衰竭患者肌少症的筛查及干预研究[J]. 中华全科医学, 2022, 20(3): 419-423. doi: 10.16766/j.cnki.issn.1674-4152.002367

    MA L Y, LIN P, WANG Q, et al. Screening and intervention of sarcopoenia in elderly patients with chronic heart failure[J]. Chinese Journal of General Practice, 2022, 20(3): 419-423. doi: 10.16766/j.cnki.issn.1674-4152.002367
    [15]
    PASDAR Y, DARBANDI M, REZAEIAN S, et al. Association of obesity, sarcopenia, and sarcopenic obesity with hypertension in adults: A cross-sectional study from Ravansar, Iran during 2014-2017[J]. Front Public Health, 2022, 9: 705055. DOI: 10.3389/fpubh.2021.705055.
    [16]
    ZAMBONI M, RUBELE S, ROSSI A P. Sarcopenia and obesity[J]. Curr Opin Clin Nutr Metab Care, 2019, 22(1): 13-19. doi: 10.1097/MCO.0000000000000519
    [17]
    LIVSHITS G, KALINKOVICH A. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis[J]. Ageing Res Rev, 2019, 56(8): 100980. DOI: 10.1016/j.arr.2019.100980.
    [18]
    GUARALDI G, MILIC J, SEBASTIANI G, et al. Sarcopenic obesity at the crossroad of pathogenesis of cardiometabolic diseases[J]. Atherosclerosis, 2021, 335(10): 84-86.
    [19]
    SUN T, MA Z, GAO L, et al. Correlation between sarcopenia and arteriosclerosis in elderly community dwellers: A multicenter study[J]. J Nutr Health Aging, 2021, 25(5): 692-697. doi: 10.1007/s12603-021-1624-4
    [20]
    TAKAHASHI F, HASHIMOTO Y, KAJI A, et al. Sarcopenic obesity is associated with macroalbuminuria in patients with type 2 diabetes: A cross-sectional study[J]. Endocr J, 2021, 68(7): 781-789. doi: 10.1507/endocrj.EJ20-0655
    [21]
    EVANS K, ABDELHAFIZ D, ABDELHAFIZ A H. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: A systematic review[J]. Postgrad Med, 2021, 133(8): 831-842. doi: 10.1080/00325481.2021.1942934
    [22]
    LIM H S, PARK Y H, SUH K, et al. Association between sarcopenia, sarcopenic obesity, and chronic disease in Korean elderly[J]. J Bone Metab, 2018, 25(3): 187-193. doi: 10.11005/jbm.2018.25.3.187
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Article Metrics

    Article views (176) PDF downloads(5) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return